Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recessive oncogenes: current status.

Xiang Gao1, Kenneth V Honn

  • 1Wayne State University, School of Medicine, Department of Radiation Oncology, Detroit, USA.

Pathology Oncology Research : POR
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thrombocytosis in cancer patients: when more is not better-in fact, the opposite.

Cancer metastasis reviews·2026
Same author

Tissue factor pathway inhibitor-2 (TFPI-2)-an underappreciated partaker in cancer and metastasis.

Cancer metastasis reviews·2024
Same author

The Complex Role of Thrombin in Cancer and Metastasis: Focus on Interactions with the Immune System.

Seminars in thrombosis and hemostasis·2023
Same author

Inflammation, lipid dysregulation, and transient receptor potential cation channel subfamily V member 4 signaling perpetuate chronic vulvar pain.

Pain·2023
Same author

Newly identified form of phenotypic plasticity of cancer: immunogenic mimicry.

Cancer metastasis reviews·2023
Same author

The Role and Regulation of Thromboxane A<sub>2</sub> Signaling in Cancer-Trojan Horses and Misdirection.

Molecules (Basel, Switzerland)·2022
Same journal

B vitamins intake and cancer risk: a structured narrative review of evidence on riboflavin, pyridoxine, cobalamin and folate.

Pathology oncology research : POR·2026
Same journal

Multiple subcutaneous nodules as the primary presentation of angioimmunoblastic T-cell lymphoma: a case report and literature review.

Pathology oncology research : POR·2026
Same journal

<i>Connexin 43</i> enhances liver metastatic ability of GIST cells <i>in vivo</i>.

Pathology oncology research : POR·2026
Same journal

Proof-of-principle 4-marker spatial profiling reveals distinct, location-independent immune clusters in biliary tract cancers.

Pathology oncology research : POR·2026
Same journal

Genotyping of suspected partial hydatidiform moles - our experiences and future directions.

Pathology oncology research : POR·2026
Same journal

Prognostic impact of p53 and HER2 immunohistochemistry profiles in colorectal carcinoma.

Pathology oncology research : POR·2026
See all related articles

Tumor suppressor genes act as cell cycle brakes. Their inactivation, through various mechanisms, can lead to uncontrolled cell growth and cancer formation, often involving multiple genetic alterations.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cell growth is regulated by a balance of positive and negative signals.
  • Tumor suppressor genes, or recessive oncogenes, encode proteins that act as negative regulators of the cell cycle.
  • Inactivation of these genes can lead to uncontrolled cell proliferation and tumor formation.

Purpose of the Study:

  • To provide an overview of identified tumor suppressor genes, including their structure, function, and mechanisms of action.
  • To discuss the role of tumor suppressor genes in the development of various human malignancies.
  • To review chromosomal regions potentially harboring novel tumor suppressor genes.

Main Methods:

  • Literature review of identified tumor suppressor genes (RB, p53, DCC, APC, MCC, WT1, VHL, MST1, BRCA1).

Related Experiment Videos

  • Analysis of the involvement of tumor suppressor genes in human cancers, with a focus on prostate cancer.
  • Review of chromosomal regions associated with tumor suppressor genes.

    • Main Results:

    • Numerous tumor suppressor genes have been identified, with varying roles in different cancer types.
    • Examples include well-known genes like p53 and RB, as well as more specific ones like NF-1.
    • Tumorigenesis often results from the accumulation of alterations in multiple tumor suppressor genes.

    Conclusions:

    • Tumor suppressor genes are critical in preventing cancer.
    • Understanding their inactivation mechanisms and roles in specific cancers is crucial for developing targeted therapies.
    • Further research into novel tumor suppressor genes and their genomic locations is warranted.